Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fondaparinux in Acute Heparin-Induced Thrombocytopenia
NCT00603824Phase 4Withdrawn
- Sponsor
- Methodist Healthcare System of San Antonio
- Start
- Jan 2008
- Primary completion
- Jul 2009
- Modality
- Allosteric Modulators
01
Overview
A Phase 4 trial of fondaparinux in heparin-induced thrombocytopenia (HIT), sponsored by Methodist Healthcare System of San Antonio. Planned start Jan 2008; status: withdrawn.
02
Drugs
fondaparinux
03
Conditions
heparin-induced thrombocytopenia (HIT)
Beyond the preview
Go deeper on NCT00603824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603824.